Jonathan Scargill

Reduced Testing Frequency for Glycated Hemoglobin, HbA1c, Is Associated With Deteriorating Diabetes Control

Owen John Driskell, David P. Holland, Jenna Louise Waldron et al. · Diabetes Care · 2014 · 72 citations · Full text

The frequency of testing for glycated haemoglobin, HbA_1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus

Christopher J. Duff, Ivonne Solis‐Trapala, Owen John Driskell et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2018 · 25 citations

Glycated Haemoglobin, Diabetes Management, Target Levels +11

Monitoring Thyroid Function in Patients on Levothyroxine. Assessment of Conformity to National Guidance and Variability in Practice

Jonathan Scargill, Mark Livingston, David P. Holland et al. · Experimental and Clinical Endocrinology & Diabetes · 2017 · 21 citations

Impact of the UK COVID‐19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management

David P. Holland, Adrian Heald, Mike Stedman et al. · International Journal of Clinical Practice · 2021 · 18 citations · Full text

Uk Covid‐19 Pandemic, Point-of-care Testing, United Kingdom +23

The Effect of the COVID-19 Pandemic on HbA1c Testing: Prioritization of High-Risk Cases and Impact of Social Deprivation

David P. Holland, Adrian Heald, Fahmy Hanna et al. · Diabetes Therapy · 2023 · 11 citations · Full text